US42226K1051
US42226K1051
Healthcare Realty Trust Incorpo
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 6.02B EUR | 6.91B EUR | 5.89B EUR | 5.96B EUR |
Enterprise Value | 10.33B EUR | 11.3B EUR | 10.2B EUR | 10.08B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 381.11x | -- | -- | -- |
Price to Sales | 5.24x | 6.19x | 5.2x | 6.98x |
Price to Book | 1.39x | 1.64x | 1.33x | 1.29x |
EV/Revenue | 8.99x | 10.12x | 9.01x | 11.81x |
EV/EBITDA | 14.72x | 16.16x | 14.72x | 19.38x |
Price to FCF (P/FCF) | 12.2x | 51.27x | 42.05x | 40.19x |
EV/FCF | 20.94x | 83.78x | 72.86x | 67.99x |
FCF Yield | 8.2% | 1.95% | 2.38% | 2.49% |